GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
340.54
+0.10 (0.03%)
At close: Aug 20, 2026

GlaxoSmithKline Pakistan Cash Flow Statement

Millions PKR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
10,50910,0256,536533.952,4635,354
Depreciation & Amortization
1,4271,3741,136932.3859.38775.27
Loss (Gain) From Sale of Assets
-82.24-74.07-21.88-82.76-124.62-633.9
Asset Writedown & Restructuring Costs
42.0142.0118.396.0118.0215.54
Provision & Write-off of Bad Debts
21.5121.511.76160.3489.742.74
Other Operating Activities
-1,301180.421,552-703.15-431.511,204
Change in Accounts Receivable
-2,592-2,279471.58395.71-358.67-154.15
Change in Inventory
-550.23-2,739-365.39-2,256-3,363-1,077
Change in Accounts Payable
1,371557.26-1,0094,3322,827-36.69
Change in Other Net Operating Assets
1,3761,555-3,257-1,386-5,142-512.05
Operating Cash Flow
10,2128,6645,0581,884-3,1614,987
Operating Cash Flow Growth
105.56%71.30%168.51%---16.33%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2,455-2,583-2,775-1,649-1,533-1,304
Sale of Property, Plant & Equipment
257.21275.65134.32212.95244.47777.27
Other Investing Activities
517.66518.14538.91279.45827.1374.94
Investing Cash Flow
-1,681-1,789-2,102-1,157-461.6-151.56

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--54.31-51.12-25.59-14.6-11.46
Net Debt Issued (Repaid)
-65.52-54.31-51.12-25.59-14.6-11.46
Common Dividends Paid
-4,743-4,742-1.76-1,845-375.03-2,062
Financing Cash Flow
-4,809-4,796-52.88-1,871-389.63-2,073

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
3,7222,0792,903-1,144-4,0122,762

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
7,7566,0812,282234.56-4,6943,683
Free Cash Flow Growth
206.14%166.44%873.04%---20.69%
Free Cash Flow Margin
11.52%9.23%3.73%0.47%-11.22%10.05%
Free Cash Flow Per Share
24.3519.097.170.74-14.7411.57
Levered Free Cash Flow
8,4796,7583,051-1,126-1,4733,545
Unlevered Free Cash Flow
8,4796,7853,063-1,122-1,4703,549

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
9,0987,2842,6982,3092,639871.59
Change in Working Capital
-396.1-2,906-4,1601,085-6,036-1,780